跳至主要内容
临床试验/NCT07643077
NCT07643077进行中(未招募)不适用

CHARACTERIZATION OF THE OCULAR SURFACE MICROBIOME IN THE REGION OF EPIRUS AND MACEDONIA (GREECE)

University of Ioannina1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2024年3月20日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
45
试验地点
1

研究概览

简要总结

The effect of latanoprost with preservatives on the ocular surface microbiome

详细描述

Evidence suggests that the ocular surface microbiome of patients using preserved glaucoma eye drops differs from that of healthy individuals. These microbial changes have been linked to both the glaucoma treatment itself and the presence of preservatives, particularly benzalkonium chloride (BAK), in the eye drops. However, existing studies have primarily assessed these differences by comparing treated glaucoma patients to healthy controls, rather than examining changes within the same individuals over time.

The aim of this study is to evaluate how glaucoma medications containing the preservative benzalkonium chloride affect the ocular surface microbiome in the same patients before and after the initiation of therapy.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Newly diagnosed treatment naive glaucoma patients or those with ocular hypertension

排除标准

  • Patients' history of recent ocular surgery or trauma,
  • Patient with any type of conjunctivitis and ocular surface inflammation recent to the time of diagnosis
  • Patients using topical antibiotics
  • Contact lenses wearers
  • Patients in other chronic treatments with eye drops

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andreas Katsanos

Head, Ophthalmology Department, University Hospital of Ioannina, Greece

University of Ioannina

研究点 (1)

Loading locations...

相似试验